Skip to main content
    Q

    Quoin Pharmaceuticals Ltd DRC (QNRX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.46
    -0.10 (-2.81%)

    Market Cap: $17.78M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Quoin Pharmaceuticals Ltd DRC (QNRX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Quoin Pharmaceuticals Ltd DRC (QNRX) has a market cap of $17.78M and an enterprise value of $7.68M. Its share count is up 757.28% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 56.82% below the market cap, as cash exceeds debt.

    Market Cap$17.78M
    Enterprise Value$7.68M
    Latest price (Nov 17, 2026)$3.46

    Key Dates

    The next earnings report is expected on Mar 24, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 24, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 151.05% in the quarter ended Sep 30, 2026.

    Shares Outstanding5.04M
    Shares Change (YoY)+757.28%
    Shares Change (QoQ)+151.05%

    Valuation Ratios

    P/B Ratio0.6x
    P/TBV Ratio0.6x

    Price Statistics

    The stock is down 76.98% over 52 weeks and trades 28.66% below its 50-day average.

    Beta (1Y)0.83
    52-Week Change-76.98%
    1-Month Change-13.07%
    3-Month Change-26.69%
    6-Month Change-33.08%
    5-Year Change-99.99%
    10-Year Change-100.00%
    Total Return (1Y)-76.98%
    Total Return (3Y CAGR)-71.90%
    Total Return (5Y CAGR)-83.32%
    Return vs SPY (1Y)-93.58%
    Max Drawdown (1Y)-85.43%
    Max Drawdown (3Y)-98.28%
    Sharpe Ratio (1Y)-1.57
    Correlation with SPY (1Y)0.10
    50-Day Average$4.85
    200-Day Average$5.72
    52-Week Range$3.25 to $23.50
    RSI (14 Days)32.5
    Average Volume (20 Days)11.84K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 7.20x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio7.20x
    Quick Ratio7.20x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -68.58% and return on assets is -56.64% over the last 12 months.

    Return on Equity (ROE)-68.58%
    Return on Assets (ROA)-56.64%

    Scores

    QNRX has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Operating Income-$20.14M
    Pretax Income-$19.68M
    Net Income-$19.68M
    Reported EPS (TTM)-$6.38

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 82.59% of the $34.75M in total assets.

    Cash and Equivalents$10.10M
    Total Debt$0
    Net Cash$10.10M
    Working Capital$29.62M
    Shareholder Equity$28.70M
    Tangible Book Value$28.39M
    Total Assets$34.75M
    Total Liabilities$6.05M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $7 of capital spending, operating cash flow left -$18.93M of free cash flow.

    Operating Cash Flow-$18.93M
    Capital Expenditures$7
    Free Cash Flow-$18.93M
    FCF Per Share-$3.94
    Depreciation and Amortization$100.43K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Stock Splits

    The last split was a 1-for-35 reverse split on Apr 9, 2025.

    Last Split DateApr 9, 2025
    Split TypeReverse split
    Split Ratio1:35

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About QNRX

    What is QNRX's market cap?

    Quoin Pharmaceuticals Ltd DRC has a market cap of $17.78M. Its enterprise value, which adds debt and subtracts cash, is $7.68M.

    How many shares of QNRX are outstanding?

    Quoin Pharmaceuticals Ltd DRC has 5.04M shares outstanding. The count is up 757.28% from a year earlier.

    Does QNRX pay a dividend?

    No. Quoin Pharmaceuticals Ltd DRC does not pay a dividend.

    How much debt does QNRX have?

    Quoin Pharmaceuticals Ltd DRC has $0 of total debt and $10.10M of cash and equivalents, a net cash position of $10.10M.